- Home
- BCAB vs OCCI Comparison
BCAB vs OCCI Comparison
Compare BCAB & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- OCCI
- Stock Information
- Founded
- BCAB 2007
- OCCI N/A
- Country
- BCAB United States
- OCCI United States
- Employees
- BCAB N/A
- OCCI N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- BCAB Health Care
- OCCI Finance
- Exchange
- BCAB Nasdaq
- OCCI Nasdaq
- Market Cap
- BCAB 22.3M
- OCCI 160.5M
- IPO Year
- BCAB 2020
- OCCI N/A
- Fundamental
- Price
- BCAB $0.39
- OCCI $6.25
- Analyst Decision
- BCAB Buy
- OCCI
- Analyst Count
- BCAB 2
- OCCI 0
- Target Price
- BCAB $1.00
- OCCI N/A
- AVG Volume (30 Days)
- BCAB 550.8K
- OCCI 115.8K
- Earning Date
- BCAB 08-07-2025
- OCCI 12-11-2023
- Dividend Yield
- BCAB N/A
- OCCI 24.32%
- EPS Growth
- BCAB N/A
- OCCI N/A
- EPS
- BCAB N/A
- OCCI N/A
- Revenue
- BCAB $11,000,000.00
- OCCI N/A
- Revenue This Year
- BCAB N/A
- OCCI N/A
- Revenue Next Year
- BCAB N/A
- OCCI $10.19
- P/E Ratio
- BCAB N/A
- OCCI N/A
- Revenue Growth
- BCAB N/A
- OCCI N/A
- 52 Week Low
- BCAB $0.24
- OCCI $5.47
- 52 Week High
- BCAB $2.53
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- BCAB 52.08
- OCCI 51.26
- Support Level
- BCAB $0.36
- OCCI $6.21
- Resistance Level
- BCAB $0.42
- OCCI $6.30
- Average True Range (ATR)
- BCAB 0.03
- OCCI 0.07
- MACD
- BCAB 0.00
- OCCI 0.02
- Stochastic Oscillator
- BCAB 71.57
- OCCI 82.76
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.